Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
362
NCT01794663
Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2012
Completion: Jun 30, 2016
NCT02363491
A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome
Phase: Phase 1/2
Start: Jan 31, 2015
Completion: Dec 31, 2018
NCT03337451
Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome
Start: Feb 27, 2018
Completion: Jan 10, 2019